Natural Product: NPC212376

Natural Product IDNPC212376
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
N-Lignoceroyltryptamine
IUPAC Name N-[2-(1H-indol-3-yl)ethyl]tetracosanamide
Synonyms N-Lignoceroyltryptamine
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL492171
PubChem CID 10174581
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000211] Indoles and derivatives
        • [CHEMONTID:0002497] Indoles
          • [CHEMONTID:0004196] 3-alkylindoles

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey LQPINJBBNVSTDE-UHFFFAOYSA-N
Standard InCHI InChI=1S/C34H58N2O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-27-34(37)35-29-28-31-30-36-33-26-24-23-25-32(31)33/h23-26,30,36H,2-22,27-29H2,1H3,(H,35,37)
SMILES CCCCCCCCCCCCCCCCCCCCCCCC(=NCCc1c[nH]c2ccccc12)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   510.45 Volume:   597.108
?
Van der Waals volume.
Dense:   0.855 LogP:   9.646
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   4.954
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.789
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   25.0 Rigid Bonds:   11.0
TPSA:   48.38
?
Topological Polar Surface Area.
H-Bond Acceptor:   3.0
H-Bond Donor:   2.0 Rings:   2.0
Heavy Atoms:   3.0

MedChem Properties

QED Drug-Likeness Score:   0.078 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.575 Fsp3:   0.735
MCE-18:   10.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.714 Fluc inhibitor:   0.09
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.053
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.363
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.006 Promiscuous compounds:   0.246

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.068 MDCK Permeability:   -4.901
Pgp-inhibitor:   0.0 Pgp-substrate:   0.175
PAMPA:   0.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.976
20% Bioavailability (F20%):   0.994 30% Bioavailability (F30%):   1.0
50% Bioavailability (F50%):   0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.004 MRP1:   0.948
Plasma Protein Binding (PPB):   101.569% Volume Distribution (VD):   1.988
Fu: 0.347%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.643
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.99
BSEP inhibitor:   0.833

ADMET: Metabolism

CYP1A2-inhibitor:   0.001 CYP1A2-substrate:   0.98
CYP2C19-inhibitor:   0.106 CYP2C19-substrate:   0.438
CYP2C9-inhibitor:   1.0 CYP2C9-substrate:   0.921
CYP2D6-inhibitor:   1.0 CYP2D6-substrate:   0.538
CYP3A4-inhibitor:   0.452 CYP3A4-substrate:   0.999
CYP2B6-substrate:   0.407 CYP2C8-inhibitor:   1.0
HLM stability:   0.776
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  4.642 Half-life (T1/2):  2.193

ADMET: Toxicity

hERG Blockers:  0.718 hERG Blockers (10um):  0.897
Human Hepatotoxicity (H-HT):  0.836 Drug-induced Liver Injury (DILI):  0.312
AMES Toxicity:  0.132 Rat Oral Acute Toxicity:  0.491
Maximum Recommended Daily Dose:  0.636 Skin Sensitization:  0.999
Carcinogencity:  0.605 Eye Corrosion:  0.008
Eye Irritation:  0.893 Respiratory Toxicity:  0.996
Drug-induced Neurotoxicity:  0.013 Ototoxicity:  0.402
Hematotoxicity:  0.211 Drug-induced Nephrotoxicity:  0.354
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.012
A549 Cytotoxicity:  0.833 Hek293 Cytotoxicity:  0.16
BCF:   0.54
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   5.215
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.675
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.49
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32731 rollinia mucosa Species Annonaceae Eukaryota seeds n.a. n.a. PMID[10479316]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell line A549 Homo sapiens ED50 > 10.0 ug ml-1 DOI[10.6019/CHEMBL1201861]
NPT83 Cell line MCF7 Homo sapiens ED50 > 10.0 ug ml-1 DOI[10.6019/CHEMBL1201861]
NPT139 Cell line HT-29 Homo sapiens ED50 > 10.0 ug ml-1 PMID[10479318]
NPT306 Cell line PC-3 Homo sapiens ED50 > 10.0 ug ml-1 PMID[23755850]
NPT783 Cell line MIA PaCa-2 Homo sapiens ED50 > 10.0 ug ml-1 PMID[16448174]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. ED50 > 10.0 ug ml-1 PMID[10479316]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference
- Artemia salina LC50 > 500.0 ug.mL-1 PMID[7562925]

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC212376 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC259644
1.0 High Similarity NPC70922
1.0 High Similarity NPC211572
1.0 High Similarity NPC75540
1.0 High Similarity NPC469765
1.0 High Similarity NPC80597
1.0 High Similarity NPC25008
1.0 High Similarity NPC73952
0.8475 Intermediate Similarity NPC469763
0.75 Intermediate Similarity NPC190296
0.7333 Intermediate Similarity NPC105818
0.7273 Intermediate Similarity NPC311276
0.6769 Remote Similarity NPC24678
0.5968 Remote Similarity NPC469760
0.5968 Remote Similarity NPC469786
0.5932 Remote Similarity NPC471957
0.5254 Remote Similarity NPC59269
0.5195 Remote Similarity NPC486585
0.5156 Remote Similarity NPC279918
0.5143 Remote Similarity NPC75907
0.5079 Remote Similarity NPC282231
0.5079 Remote Similarity NPC267885
0.5068 Remote Similarity NPC277920

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC212376 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data